Listed

Medifast Inc

MEDNYSECIK 910329Consumer staplesFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$76.4m, Q2 FY2026
Operating income−$4.3m, Q2 FY2026
Net income−$3.1m, Q2 FY2026
Medifast Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m236Revenue, Q3 FY2023, three months to 2023-09-30$235.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure191Revenue, Q4 FY2023, three months to 2023-12-31$191.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure175Revenue, Q1 FY2024, three months to 2024-03-31$174.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure169Revenue, Q2 FY2024, three months to 2024-06-30$168.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure140Revenue, Q3 FY2024, three months to 2024-09-30$140.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure119Revenue, Q4 FY2024, three months to 2024-12-31$119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure116Revenue, Q1 FY2025, three months to 2025-03-31$115.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure106Revenue, Q2 FY2025, three months to 2025-06-30$105.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure89.4Revenue, Q3 FY2025, three months to 2025-09-30$89.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure75.1Revenue, Q4 FY2025, three months to 2025-12-31$75.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure76.0Revenue, Q1 FY2026, three months to 2026-03-31$76.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure76.4Revenue, Q2 FY2026, three months to 2026-06-30$76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Cost of revenue$m58.5Cost of revenue, Q3 FY2023, three months to 2023-09-30$58.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure49.6Cost of revenue, Q4 FY2023, three months to 2023-12-31$49.6m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure47.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$47.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure45.1Cost of revenue, Q2 FY2024, three months to 2024-06-30$45.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure34.5Cost of revenue, Q3 FY2024, three months to 2024-09-30$34.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure30.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$30.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure31.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$31.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure28.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$28.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure27.3Cost of revenue, Q3 FY2025, three months to 2025-09-30$27.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure23.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$23.0m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure24.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$24.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure23.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$23.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Gross profit$m177Gross profit, Q3 FY2023, three months to 2023-09-30$177.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure141Gross profit, Q4 FY2023, three months to 2023-12-31$141.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure127Gross profit, Q1 FY2024, three months to 2024-03-31$127.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure123Gross profit, Q2 FY2024, three months to 2024-06-30$123.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure106Gross profit, Q3 FY2024, three months to 2024-09-30$105.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure88.2Gross profit, Q4 FY2024, three months to 2024-12-31$88.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure84.2Gross profit, Q1 FY2025, three months to 2025-03-31$84.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure76.6Gross profit, Q2 FY2025, three months to 2025-06-30$76.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure62.2Gross profit, Q3 FY2025, three months to 2025-09-30$62.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure52.1Gross profit, Q4 FY2025, three months to 2025-12-31$52.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure51.8Gross profit, Q1 FY2026, three months to 2026-03-31$51.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure53.4Gross profit, Q2 FY2026, three months to 2026-06-30$53.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Selling, general and administrative$m152Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$151.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure133Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$132.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure119Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$119.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure131Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$131.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure104Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$103.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure87.5Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$87.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure85.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$85.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure77.7Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$77.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure66.2Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$66.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure59.9Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$59.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure55.1Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$55.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure57.7Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$57.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Operating income$m25.5Operating income, Q3 FY2023, three months to 2023-09-30$25.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure8.7Operating income, Q4 FY2023, three months to 2023-12-31$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure7.9Operating income, Q1 FY2024, three months to 2024-03-31$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure(7.9)Operating income, Q2 FY2024, three months to 2024-06-30−$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure2.1Operating income, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure0.7Operating income, Q4 FY2024, three months to 2024-12-31$709.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(1.3)Operating income, Q1 FY2025, three months to 2025-03-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(1.1)Operating income, Q2 FY2025, three months to 2025-06-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(4.1)Operating income, Q3 FY2025, three months to 2025-09-30−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure(7.8)Operating income, Q4 FY2025, three months to 2025-12-31−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(3.3)Operating income, Q1 FY2026, three months to 2026-03-31−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(4.3)Operating income, Q2 FY2026, three months to 2026-06-30−$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Income tax$m3.4Income tax, Q3 FY2023, three months to 2023-09-30$3.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure3.8Income tax, Q4 FY2023, three months to 2023-12-31$3.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure3.3Income tax, Q1 FY2024, three months to 2024-03-31$3.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure(2.5)Income tax, Q2 FY2024, three months to 2024-06-30−$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure0.4Income tax, Q3 FY2024, three months to 2024-09-30$449.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure0.5Income tax, Q4 FY2024, three months to 2024-12-31$474.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure1.3Income tax, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure0.4Income tax, Q2 FY2025, three months to 2025-06-30$395.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(0.4)Income tax, Q3 FY2025, three months to 2025-09-30−$396.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure11.7Income tax, Q4 FY2025, three months to 2025-12-31$11.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2026, three months to 2026-03-31$181.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$109.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Net income$m23.1Net income, Q3 FY2023, three months to 2023-09-30$23.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure6.0Net income, Q4 FY2023, three months to 2023-12-31$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure8.3Net income, Q1 FY2024, three months to 2024-03-31$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure(8.2)Net income, Q2 FY2024, three months to 2024-06-30−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure1.1Net income, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure0.8Net income, Q4 FY2024, three months to 2024-12-31$801.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(0.8)Net income, Q1 FY2025, three months to 2025-03-31−$772.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure2.5Net income, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(2.3)Net income, Q3 FY2025, three months to 2025-09-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure(18.1)Net income, Q4 FY2025, three months to 2025-12-31−$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(2.1)Net income, Q1 FY2026, three months to 2026-03-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(3.1)Net income, Q2 FY2026, three months to 2026-06-30−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Diluted EPS$ per share2.12Diluted EPS, Q3 FY2023, three months to 2023-09-30$2.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figurenot reported0.76Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure(0.75)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure0.10Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure0.22Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(0.21)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figurenot reported(0.19)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(0.28)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Basic EPS$ per share2.12Basic EPS, Q3 FY2023, three months to 2023-09-30$2.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figurenot reported0.76Basic EPS, Q1 FY2024, three months to 2024-03-31$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure(0.75)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure0.10Basic EPS, Q3 FY2024, three months to 2024-09-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figurenot reported(0.07)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure0.23Basic EPS, Q2 FY2025, three months to 2025-06-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(0.21)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figurenot reported(0.19)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(0.28)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure

Balance sheet

Cash and equivalents$71.9m, Q2 FY2026
Shareholders' equity$196.4m, Q2 FY2026
Medifast Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m113Cash and equivalents, Q3 FY2023, at 2023-09-30$112.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001628280-23-037080.Report this figure94.4Cash and equivalents, FY2023, at 2023-12-31$94.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure97.5Cash and equivalents, Q1 FY2024, at 2024-03-31$97.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-29, accession 0001628280-24-019046.Report this figure108Cash and equivalents, Q2 FY2024, at 2024-06-30$108.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-05, accession 0001628280-24-034791.Report this figure115Cash and equivalents, Q3 FY2024, at 2024-09-30$115.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure90.9Cash and equivalents, FY2024, at 2024-12-31$90.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure91.7Cash and equivalents, Q1 FY2025, at 2025-03-31$91.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure102Cash and equivalents, Q2 FY2025, at 2025-06-30$101.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure99.5Cash and equivalents, Q3 FY2025, at 2025-09-30$99.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure89.3Cash and equivalents, FY2025, at 2025-12-31$89.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure71.5Cash and equivalents, Q1 FY2026, at 2026-03-31$71.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure71.9Cash and equivalents, Q2 FY2026, at 2026-06-30$71.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Current assets$m224Current assets, Q3 FY2023, at 2023-09-30$224.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001628280-23-037080.Report this figure224Current assets, FY2023, at 2023-12-31$224.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure220Current assets, Q1 FY2024, at 2024-03-31$219.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-29, accession 0001628280-24-019046.Report this figure224Current assets, Q2 FY2024, at 2024-06-30$224.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-05, accession 0001628280-24-034791.Report this figure225Current assets, Q3 FY2024, at 2024-09-30$225.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure214Current assets, FY2024, at 2024-12-31$214.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure214Current assets, Q1 FY2025, at 2025-03-31$213.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure206Current assets, Q2 FY2025, at 2025-06-30$206.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure208Current assets, Q3 FY2025, at 2025-09-30$207.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure202Current assets, FY2025, at 2025-12-31$201.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure203Current assets, Q1 FY2026, at 2026-03-31$202.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure202Current assets, Q2 FY2026, at 2026-06-30$202.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Total assets$m320Total assets, Q3 FY2023, at 2023-09-30$320.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001628280-23-037080.Report this figure310Total assets, FY2023, at 2023-12-31$309.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure303Total assets, Q1 FY2024, at 2024-03-31$302.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-29, accession 0001628280-24-019046.Report this figure294Total assets, Q2 FY2024, at 2024-06-30$293.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-05, accession 0001628280-24-034791.Report this figure291Total assets, Q3 FY2024, at 2024-09-30$291.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure284Total assets, FY2024, at 2024-12-31$284.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure280Total assets, Q1 FY2025, at 2025-03-31$280.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure269Total assets, Q2 FY2025, at 2025-06-30$269.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure268Total assets, Q3 FY2025, at 2025-09-30$268.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure248Total assets, FY2025, at 2025-12-31$248.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure252Total assets, Q1 FY2026, at 2026-03-31$252.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure260Total assets, Q2 FY2026, at 2026-06-30$260.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Current liabilities$m110Current liabilities, Q3 FY2023, at 2023-09-30$110.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001628280-23-037080.Report this figure92.3Current liabilities, FY2023, at 2023-12-31$92.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure77.2Current liabilities, Q1 FY2024, at 2024-03-31$77.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-29, accession 0001628280-24-019046.Report this figure75.2Current liabilities, Q2 FY2024, at 2024-06-30$75.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-05, accession 0001628280-24-034791.Report this figure72.4Current liabilities, Q3 FY2024, at 2024-09-30$72.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure64.2Current liabilities, FY2024, at 2024-12-31$64.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure60.6Current liabilities, Q1 FY2025, at 2025-03-31$60.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure46.2Current liabilities, Q2 FY2025, at 2025-06-30$46.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure46.7Current liabilities, Q3 FY2025, at 2025-09-30$46.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure43.0Current liabilities, FY2025, at 2025-12-31$43.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure42.2Current liabilities, Q1 FY2026, at 2026-03-31$42.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure41.6Current liabilities, Q2 FY2026, at 2026-06-30$41.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Total liabilities$m127Total liabilities, Q3 FY2023, at 2023-09-30$127.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001628280-23-037080.Report this figure108Total liabilities, FY2023, at 2023-12-31$108.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure91.8Total liabilities, Q1 FY2024, at 2024-03-31$91.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-29, accession 0001628280-24-019046.Report this figure88.2Total liabilities, Q2 FY2024, at 2024-06-30$88.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-05, accession 0001628280-24-034791.Report this figure83.9Total liabilities, Q3 FY2024, at 2024-09-30$83.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure74.1Total liabilities, FY2024, at 2024-12-31$74.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure69.1Total liabilities, Q1 FY2025, at 2025-03-31$69.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure53.3Total liabilities, Q2 FY2025, at 2025-06-30$53.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure53.5Total liabilities, Q3 FY2025, at 2025-09-30$53.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure49.1Total liabilities, FY2025, at 2025-12-31$49.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure54.4Total liabilities, Q1 FY2026, at 2026-03-31$54.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure64.0Total liabilities, Q2 FY2026, at 2026-06-30$64.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m193Shareholders' equity, Q3 FY2023, at 2023-09-30$193.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure201Shareholders' equity, FY2023, at 2023-12-31$201.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure211Shareholders' equity, Q1 FY2024, at 2024-03-31$211.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure205Shareholders' equity, Q2 FY2024, at 2024-06-30$205.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure207Shareholders' equity, Q3 FY2024, at 2024-09-30$207.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure210Shareholders' equity, FY2024, at 2024-12-31$210.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure211Shareholders' equity, Q1 FY2025, at 2025-03-31$211.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure216Shareholders' equity, Q2 FY2025, at 2025-06-30$216.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure215Shareholders' equity, Q3 FY2025, at 2025-09-30$214.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure199Shareholders' equity, FY2025, at 2025-12-31$198.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure198Shareholders' equity, Q1 FY2026, at 2026-03-31$197.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure196Shareholders' equity, Q2 FY2026, at 2026-06-30$196.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure

Cash flow

Operating cash flow$1.7m, Q2 FY2026
Capital expenditure$969.0k, Q2 FY2026
Share repurchases$0, Q4 FY2024
Medifast Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m29.9Operating cash flow, Q3 FY2023, three months to 2023-09-30$29.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-04, accession 0001628280-24-045040. Derived: 9-month figure less the 6-month figure.Report this figure10.5Operating cash flow, Q4 FY2023, three months to 2023-12-31$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure7.3Operating cash flow, Q1 FY2024, three months to 2024-03-31$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure13.1Operating cash flow, Q2 FY2024, three months to 2024-06-30$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-04, accession 0000910329-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure9.1Operating cash flow, Q3 FY2024, three months to 2024-09-30$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Report this figure(4.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure3.4Operating cash flow, Q1 FY2025, three months to 2025-03-31$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(3.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figure12.1Operating cash flow, Q3 FY2025, three months to 2025-09-30$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Report this figure(5.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure0.3Operating cash flow, Q1 FY2026, three months to 2026-03-31$260.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure1.7Operating cash flow, Q2 FY2026, three months to 2026-06-30$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-04, accession 0001628280-24-045040. Derived: 9-month figure less the 6-month figure.Report this figure0.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$946.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure1.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure1.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-04, accession 0000910329-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure1.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Report this figure2.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure1.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure1.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figure1.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Report this figure1.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure1.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure1.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$969.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$m18.0Dividends paid, Q3 FY2023, three months to 2023-09-30$18.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-11-04, accession 0001628280-24-045040. Derived: 9-month figure less the 6-month figure.Report this figure18.0Dividends paid, Q4 FY2023, three months to 2023-12-31$18.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure0.7Dividends paid, Q1 FY2024, three months to 2024-03-31$710.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure0.0Dividends paid, Q2 FY2024, three months to 2024-06-30$4.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-08-04, accession 0000910329-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure0.0Dividends paid, Q3 FY2024, three months to 2024-09-30$1.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Report this figure0.0Dividends paid, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure0.2Dividends paid, Q1 FY2025, three months to 2025-03-31$194.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure0.0Dividends paid, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figure0.0Dividends paid, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Report this figure0.0Dividends paid, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure0.1Dividends paid, Q1 FY2026, three months to 2026-03-31$87.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure0.1Dividends paid, Q2 FY2026, three months to 2026-06-30$83.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-04, accession 0001628280-24-045040. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-04-29, accession 0001628280-24-019046.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-08-05, accession 0001628280-24-034791. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-04, accession 0001628280-24-045040. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)11.13m, Q2 FY2026
Medifast Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares11.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3011,042,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001628280-23-037080.Report this figure10.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3110,899,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-29, accession 0001628280-24-019046.Report this figure10.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3010,917,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-05, accession 0001628280-24-034791.Report this figure10.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3010,933,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0001628280-24-045040.Report this figure11.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3110,958,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-28, accession 0001628280-25-020341.Report this figure10.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3010,937,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-04, accession 0000910329-25-000016.Report this figure11.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3010,971,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure10.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3110,948,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure11.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3011,060,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure11.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3010,991,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure11.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3111,006,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure11.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3011,135,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure

Shares outstanding: 11.18mShares outstanding, period not labelled, at 2026-07-2711,180,703 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure at Jul 27, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. Listed shows no prices and gives no investment advice.